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Objective: This study examined differential gene expression, histomorphometric indices and relation-
ships between these, in femoral trabecular bone from osteoarthritis (OA) patients and control (CTL)
subjects, with the aim of identifying potential molecular drivers consistent with changes in structural
and remodelling indices in the OA pathology.
Materials and methods: Bone samples from the intertrochanteric (IT) region were obtained from age and
sex-matched cohorts of 23 primary hip OA patients and 21 CTL subjects. Real-time polymerase chain
reaction (PCR) and histomorphometric analysis were performed on each sample and correlations
between gene expression and histomorphometric variables determined.
Results: Alterations in gene expression, structural indices and correlations between these were found in
OA bone compared to CTL. In OA bone, expression of critical regulators of osteoblast differentiation
(TWIST1) and function (PTEN, TIMP4) were decreased, while genes associated with inﬂammation
(SMAD3, CD14) were increased. Bone structural and formation indices (BV/TV, Tb.N, OS/BS) were
increased, whereas resorption indices (ES/BS, ES/BV) were decreased. Importantly, signiﬁcant correla-
tions in CTL bone between CTNNB1 expression and formation indices (OS/BS, OS/BV, OV/BV) were absent
in OA bone, indicating altered WNT/b-catenin signalling. TWIST1 expression and BV/TV were correlated
in CTL bone, but not in OA bone, consistent with altered osteoblastogenesis in OA. Matrix metal-
loproteinase 25 (MMP25) expression and remodelling indices (ES/BS, ES/BV, ES/TV) were correlated only
in OA pointing to aberrant bone remodelling in this pathology.
Conclusions: These ﬁndings indicate an altered state of osteoblast differentiation and function in OA
driven by several key molecular regulators. In association with this differential gene expression, an
altered state of both trabecular bone remodelling and resulting microarchitecture were also observed,
further characterising the pathogenesis of primary hip OA.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is a musculoskeletal disease known to cause
signiﬁcant disability, worldwide ﬁgures suggest it is becoming one
of the greatest health care problems in the developed world1. The
impact of OA will increase considerably as the population of
developed nations age. Primary OA is the most prevalent form and
develops in the absence of any known cause and commonly occurs
in the hip joint2.. Duminda Kumarasinghe, SA
elaide, South Australia 5000,
.
.gov.au (D.D. Kumarasinghe).
s Research Society International. PThe pathology of hip OA involves the whole joint with focal and
progressive hyaline articular cartilage loss and concomitant
changes in the subchondral bone, including development of
marginal bone outgrowths, osteophytes, and increased thickness of
the bony envelope3. In vitro and in vivo observations of subchondral
plate changes preceding articular cartilage damage suggest that
primary OA may be a bone disease, in addition to a cartilage con-
dition4e6. Early changes in OA are at the very least concomitant in
the bone and cartilage and may initiate in the bone4.
It is estimated that at least 60% of the susceptibility to hip OA is
attributable to genetic factors, and many potential candidates with
bone associated functions have been identiﬁed in familial studies5.
Linkage and association studies have identiﬁed genetic candidates
from the wingless-type MMTV integration site (WNT) signallingublished by Elsevier Ltd. All rights reserved.
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necrosis factor-a (TNFa) superfamilies, as involved in primary OA of
the hip5e7.
In a recent study utilising genemicroarray technology, a number
of differentially expressed genes were identiﬁed with potential
roles in the pathology, from the trabecular bone of end-stage OA
patients consisting of both males and females8. Among the mole-
cules identiﬁed include genes involved in osteoblast differentiation,
phosphatase and tensin homolog (PTEN), b-catenin (CTNNB1),
twist homolog 1 (TWIST1), SMAD family member 3 (SMAD3) and
S100 calcium binding protein A4 (S100A4). Other molecules iden-
tiﬁed relate to adipocyte differentiation, osteoclastogenesis and
bone remodelling, including adipocyte differentiation-related
protein (ADFP), CD14 antigen (CD14), interleukin-10 (IL10), matrix
metalloproteinase 25 (MMP25) and TIMP metallopeptidase inhib-
itor 4 (TIMP4).
Alongside the molecular changes occurring in the femoral
trabecular bone of OA patients, there are also microarchitectural
changes associatedwith the earliest symptomatic manifestations of
the disease9. Observations in the hard tissue include increased bone
volume fraction (BV/TV) and hypomineralisation9,10. Among other
histomorphometric parameters, trabecular number (Tb.N) and
osteoid surface (OS/TV) measured in the subchondral trabecular
bone of hip OA patients were found to be increased against
controls, while trabecular separation (Tb.Sp) was found to be
decreased3,14. Bone turnover also appears to be deregulated:
signiﬁcant associations between remodelling indices such as
erosion surface (ES/BS) and osteoid surface (OS/BS) and osteoclas-
togenic regulators are also uncoupled in the late stages of the
disease, suggesting that resorption in OA is regulated differently
compared to controls11.
Signiﬁcant changes in gene expression and histomorphometric
indices in trabecular bone suggest an altered remodelling state in
OA8,12. Although differences in gene expression and histo-
morphometry have been established in previous studies, as yet no
study has comprehensively examined the relationships between
these parameters and the possible contribution of these interac-
tions to the pathology13.
In this study, human intertrochanteric (IT) trabecular bone from
primary hip OA cases and non-OA controls (CTLs) was examined.
This was done to identify systemic changes in the bony compart-
ment in proximity of the disease site, away from the diseased joint
surface. The ﬁrst aim of the study was to investigate differential
expression of bone regulatory molecules between OA patients and
CTL individuals, as well as differences in histomorphometric
parameters, to explore structural and remodelling changes between
the two cohorts. The second aimwas to assess correlations between
the expression of molecular regulators, as well as correlations
between the structural histomorphometric parameters. The third
aimwas to evaluate correlations between the molecular regulators
and the histomorphometric indices. The overall aimwas to identify
associations amongst molecular drivers consistent with changes in
structural and remodelling indices within this complex pathology.
Methods
Human bone samples
Twenty-three primary end-stage OA trabecular bone samples
were obtained from patients undergoing hip arthroplasty, these
comprised 13 females and 10 males (mean age standard devia-
tion (SD); 7010 years and 6710 years, respectively). These OA
cases were macroscopically graded for OA by assessment of the
degree of ﬁbrillation and degeneration14. At surgery all OA cases
were either Grade III or Grade IV, characterised by cartilage loss,eburnation of bone, osteophytes, and remodelling of the articular
contour. Twenty-one CTL samples were obtained post-mortem
within 24 h, an approach validated by numerous previous stud-
ies8,11,15e21. These comprised 11 females and 10 males (mean
age SD; 7312 years and 6710 years, respectively). None of
the CTL cases had worse than Grade II OA, these cases were known
to be free of any extenuating bone pathologies, as described
previously8,21. No signiﬁcant difference in age was found between
OA and CTL, and between sexes (Student’s t test, P< 0.05). The
trabecular bone samples were obtained as cylindrical tube saw
biopsies from the IT region of the proximal femur. Both OA and CTL
samples were approximately 50 mm in length and 10 mm in
diameter. Each sample was divided into two equal parts, one for
histomorphometric analysis and the other for RNA extraction.
Informed consent was obtained for the collection of these speci-
mens, with approval from the Royal Adelaide Hospital Research
Ethics Committee.
RNA extraction and real-time polymerase chain reaction (PCR)
The extraction of RNA and real-time PCR was conducted as
described previously8. Trabecular bone samples were rinsed brieﬂy
in diethylpyrocarbonate-treated water and then separated into
small fragments, containing bone and marrow, using sterile
instruments. Total RNA was extracted as described previously8,18.
First-strand reverse transcription cDNA synthesis was performed
on 1 mg ampliﬁed RNA from each sample using a ﬁrst-strand cDNA
synthesis kit with Superscript II (Invitrogen, Carlsbad, CA, USA) and
250 ng random hexamer primer (Geneworks, Adelaide, SA,
Australia), in accordance with the manufacturer’s instructions.
Template cDNA (1 ml of 1/100 dilution of cDNA) was ampliﬁed using
iQ SYBR Green Supermix (BioRad, Hercules, CA, USA) on a Rotor-
Gene thermocycler (Corbett Research, Mortlake, NSW, Australia)8.
The reactions were incubated at a temperature of 94 C for 10 min
for 1 cycle, and then at 94 C (20 s), at 60 C (20 s), or at 65 C
(MMP25 only) and at 72 C (30 s) for 40 cycles. This set of cycles
was followed by an additional extension step at 72 C for 5 min. All
PCR reactions were validated by the presence of a single peak in the
melt curve analysis, and further conﬁrmed by electrophoresis on
a 2.5% weight/vol agarose gel. Primers were designed as described
previously (Geneworks, Adelaide, SA, Australia)8. Real-time PCR
validation was carried out using the 2DDCT method22. Reactions
were performed in triplicate. Gene expression cycle threshold
values were normalised to the expression of the housekeeping gene
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The genes
ampliﬁed were PTEN, CTNNB1, TWIST1, SMAD3, S100A4, ADFP,
CD14, IL10, MMP25 and TIMP48.
Histomorphometric analysis
Both the OA and CTL specimens for histomorphometry were
ﬁxed, inﬁltrated and embedded inmethylmethacrylate as described
previously23. All bone blocks were trimmed and sectioned on
a microtome (Polycut-E, Leica SP 2600, Cambridge Instruments).
Sections, 5 mm thick, were stained by the von Kossa method
and counterstained with hematoxylin and eosin to distinguish
between the mineralized bone, the cellular components of the
marrow and the osteoid. Analysis was performed on a microscope
(Leica DM6000B, Leica Microsystems) using an ocular mounted
1010 graticule at a magniﬁcation of 100. Measurements were
made of the following structural parameters: bone volume fraction
(BV/TV, %), trabecular separation (Tb.Sp, mm), trabecular thickness
(Tb.Th, mm), trabecular number (Tb.N, #/mm) and osteoid thickness
(O.Th, mm). The remodelling parameters analysed include percent
eroded speciﬁc surface (ES/BS, %), eroded surface (ES/BV, mm2/
Fig. 1. a) Photomicrograph of a 5 mm section of trabecular bone section from the IT
region of the proximal femur of a primary hip OA case (2.5 magniﬁcation). (b)
Photomicrograph of a 5 mm section of trabecular bone section from the IT region of the
proximal femur of a CTL case (2.5 magniﬁcation).
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mm3), percent osteoid speciﬁc surface (OS/BS, %), osteoid surface
(OS/BV,mm2/mm3), percent osteoid volume (OV/BV, %) and percent
osteoid surface to eroded surface (OS/ES, %)24.
Data analysis
The quantiﬁed gene expression and histomorphometry data
were tested for normality using the ShapiroeWilks statistic
(Graphpad Prism v5.00 San Deigo, CA, USA). The parametrically
distributed datasets were expressed as mean SD, the non-
parametric datasets were expressed as median (25th percentile,
75th percentile). Subsequently, as applicable, a Student’s t test or
the ManneWhitney U test was used to test for signiﬁcant differ-
ences between the OA and CTL groups for each gene and histo-
morphometric parameter. Differences between the sexes within
each cohort were examined for each parameter (data not shown);
these ﬁndings conﬁrmed the observations from the sex-pooled
cohorts. Therefore the results of the pooled datasets are presented,
consistent with previous studies20,21. Pearson product moment (r)
statistics were applied within the OA and CTL cohorts respectively,
to examine correlations between PCR product/GAPDH ratios and
between structural histomorphometric variables. Finally, correla-
tions between gene expression and the histomorphometric
parameters were assessed. The critical value for signiﬁcance was
chosen as P¼ 0.05.
Results
In this study, 23 OA and 21 CTL trabecular bone samples were
collected and all samples underwent total RNA extraction, target
gene real-time PCR and histomorphometric analysis. As we have
described previously, this approach allows analysis of gene
expression contributions from all of the cellular elements of bone,
including the bone marrow8. This provides a ‘snapshot’ of the gene
expression in both the OA and CTL bone microenvironment.
Although the speciﬁc cell type(s) contributing to the altered gene
expression cannot readily be identiﬁed, osteoblasts and osteocytes,
which represent the most abundant cells in the trabecular bone,
would be expected to contribute signiﬁcantly to the gene expres-
sion measured8,25. The comparison in gene expression and histo-
morphometric parameters, as well as correlations among these
measures, is presented below. Photomicrographs of an OA and CTL
case are presented as an example (Fig. 1).
Comparison in gene expression and histomorphometric indices
The mRNA of a number of critical signalling molecules was
found to be differentially expressed between the OA and CTL
cohorts (Table I). Of the molecules assessed, PTEN, TWIST1 (Fig. 2a),
ADFP, IL10 and TIMP4 were signiﬁcantly down-regulated in OA,
whereas SMAD3 and CD14 were up-regulated (P< 0.005).
Assessment of the histomorphometric parameters between OA
and CTL indicated that among the structural indices, BV/TV (Fig. 2b)
and Tb.N were signiﬁcantly increased in OA, whereas Tb.Sp was
signiﬁcantly decreased. Among the remodelling indices measured,
ES/BS and ES/BV were signiﬁcantly lower in OA (P< 0.05). There
was no statistically signiﬁcant difference between the groups for
the other genes and histomorphometric indices measured.
Correlations within gene expression and histomorphometry
Correlations of gene expression were examined within the OA
and CTL cohorts (Table II). A statistically signiﬁcant positive corre-
lation between PTEN and S100A4 expression was observed only inthe OA cohort. Exclusively in the CTL cohort, PTEN correlated
positively with TIMP4. Signiﬁcant positive correlations between
CTNNB1 and MMP25 were observed in both the OA and CTL
cohorts. Negative correlation between CTNNB1 and IL10 was found
in the OA samples but not in CTL. TWIST1 expression correlated
negatively with CTNNB1 and positively with S100A4, PTEN and
TIMP4, all exclusively in the OA cohort. Similarly, SMAD3 expres-
sion correlated negatively with CTNNB1 andMMP25 only in the OA
cohort. SMAD3 and CD14 expression correlated positively in both
cohorts. S100A4 expression correlated positively with IL10 and
negatively with CTNNB1 in the OA cohort alone. MMP25 and IL10
expression correlated positively only in the CTL cohort.
The quantiﬁed histomorphometric indices were examined by
correlationwithin the OA and CTL cohorts, respectively (Table II). In
both cohorts, concurrent increases in BV/TV and Tb.N and a negative
correlation between BV/TV and Tb.Sp were observed. BV/TV and
Tb.Th correlated positively exclusively in the OA cohort. Conversely,
only in the CTL cohort negative correlations betweenTb.N and Tb.Sp
and between Tb.N and O.Th were observed, alongside positive
correlations between Tb.Sp and O.Th and between Tb.Th and O.Th.Correlations between gene expression and histomorphometry
Statistically signiﬁcant correlations of bone gene expression and
histomorphometric parameters were found between a number of
Table I
Comparison of the expression of molecular regulators and structural and remodelling indices between OA patients and CTL cases*
OA CTL P-value
Gene
PTEN 0.042 (0.034, 0.051) 30 (0.077, 0.17) <0.001
CTNNB1 1.6 103 (7.2 104, 7.1 103) 7.8 104 (3.5 104, 2.0 103) 0.091
TWIST1 1.8 103 (1.0 103, 3.1 103) 3.4 103 (2.4 103, 6.3 103) 0.002
SMAD3 8.9 104 4.3 104 4.7 104 2.7 104 <0.001
S100A4 0.33 (0.16, 0.50) 0.33 (0.13, 0.45) 0.638
ADFP 0.012 (0.010, 0.018) 0.30 (0.014, 0.076) 0.002
CD14 1.7 102 (1.4 102, 2.8 102) 4.0 103 (2.7 103, 9.3 103) <0.001
IL10 6.9 105 3.8 105 1.3 104 7.0 105 0.005
MMP25 4.2 105 (6.7 106, 1.1 104) 2.2 105 (9.7 106, 6.9 105) 0.913
TIMP4 6.3 103 (3.0 103, 1.1 102) 2.4 102 (1.0 102, 5.6 102) 0.001
Histomorphometry
BV/TV (%) 8.60 (6.20, 12.10) 5.40 (4.10, 8.30) 0.009
Tb.Sp (mm) 1.04 0.40 1.87 0.90 0.007
Tb.Th (mm) 0.09 (0.07, 0.12) 0.09 (0.08, 0.11) 1.000
Tb.N (#/mm) 1.06 0.38 0.60 0.35 0.001
O.Th (mm) 3.75 (0.02, 12.46) 6.76 (0.01, 12.44) 1.000
ES/BS (%) 2.50 (1.10, 6.90) 6.80 (3.90, 9.30) 0.009
ES/BV (mm2/mm3) 0.47 (0.19, 0.97) 1.03 (0.65, 2.45) 0.018
ES/TV (mm2/mm3) 0.04 (0.02, 0.11) 0.06 (0.04, 0.18) 0.145
OS/BS (%) 6.50 (2.70, 10.60) 8.80 (4.90, 15.50) 0.097
OS/BV (mm2/mm3) 1.04 (0.60, 2.40) 1.86 (0.89, 4.97) 0.202
OV/BV (%) 1.00 (0.65, 2.47) 1.23 (0.65, 3.93) 0.572
OS/ES (%) 1.77 (0.38, 2.66) 1.04 (0.70, 4.24) 0.903
* Sampled from the IT region of the proximal femur (trabecular bone). Data are expressed as parametric mean SD or non-parametric median and inter-quartile range,
statistical signiﬁcance was set at P< 0.05. Gene expression data are expressed as mean expression normalized to GAPDH.
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CTNNB1 expression was positively correlated with OS/BS, OS/BV
and OV/BV in the CTL but not in the OA cohort (Table III). TWIST1
and BV/TV were found to be positively correlated among CTLs only
(Fig. 2c). ADFP and Tb.Sp correlated negatively exclusively in OA,
while ADFP expression and OS/ES correlated positively only in the
CTL cohort. Similarly, IL10 expression also correlated positively
with BV/TV only among the CTLs. Conversely, MMP25 expression
correlated positively with ES/BS, ES/BV and ES/TV in the OA cohort,
but not in the CTL. A positive correlation between TIMP4 expression
and O.Th was observed exclusively in the CTL cohort. All the
remaining correlations were not statistically signiﬁcant in either
cohort.
Discussion
In this study, gene expression and histomorphometric indices of
trabecular bone from 23 OA and 21 CTL cases were measured and
compared. Subsequently, correlations were assessed in the OA
cohort and in CTLs, to identify critical relationships between
molecular regulators and structural and remodelling indices.
Comparison in gene expression and histomorphometric indices
Gene expression in femoral trabecular bone indicated signiﬁ-
cantly lower levels of PTEN expression in the OA cohort compared
with CTL, consistent with previous studies8. PTEN is a known indi-
rect inhibitor of osteoblast proliferation, differentiation and miner-
alisation, an action conﬁrmed in another study using an osteoblastic
cell line26. TWIST1 expression was also lower in OA than in CTL
samples. TWIST1 is a critical regulator of downstream transcription,
whose timely expression is vital for the normal differentiation of
osteoblasts and collagen matrix mineralisation27,28. Lower expres-
sion of TWIST1 suggests deregulation of downstream factors in the
OA bone microenvironment, leading to aberrant osteoblast differ-
entiation and potentially immature osteoblasts in OA27. SMAD3was
expressed signiﬁcantly higher in OA compared to CTL. Increased
SMAD3 expression could inhibit mature osteoblast differentiationand maintain an immature osteoblast phenotype. This is consistent
with previous ﬁndings in OA, ultimately contributing to the
observed increase in bone volume fraction24e26. ADFP is a known
marker of adipocyte differentiation and currently has no established
proﬁle inhumanbone.ADFPexpression in this studywas found tobe
signiﬁcantly lower in OA. This ﬁnding is consistent with other
reports, which have found lower adipogenic potential in the bone of
hip OA cases29. However, this does not exclude other genes involved
in adipogenesis frombeing up-regulated in circulation and the joint,
consistent with the increased obesity associated with the
pathology30. CD14 expressionwas found tobe signiﬁcantly higher in
OA compared to CTL. This gene is a pan-marker of the monocyte/
macrophage phenotype, but is also expressed by granulocytes
including neutrophils31. This cell type is known to be increased in
number in OA, thus increased CD14 expression may indicate
increased recruitment of inﬂammatory cells to the IT region in OA
bone32,33. IL10 is known to reduce osteoclastogenesis, and in this
studywas found tobe signiﬁcantly lower inOA34. It is thus likely that
the decreased resorption observed in the OA cohort (signiﬁcantly
lower ES/BS and ES/BV as discussed later), maybe driven by other
regulators. For example, previous studies have found that in OA, the
critical molecular triad of OPG/RANK/RANKL may have a more
profound role in the regulation of resorption in the pathology35.
TIMP4 was signiﬁcantly down-regulated in OA when compared to
non-OA CTLs. A known inhibitor of MMPs, lower expression within
the pathology indicates increased breakdown of the extracellular
matrix in the bone microenvironment36,37.
Histoquantiﬁcation of IT trabecular bone structural and
remodelling indices indicated signiﬁcant differences in BV/TV,
Tb.Sp, Tb.N, ES/BS and ES/BV between the two cohorts (Table I). In
general, the observed differences in structural and remodelling
indices are consistent with previous changes found in OA12,38.
These include increased bone volume fraction, increased trabecular
number and decreased trabecular separation, alongside signiﬁ-
cantly decreased erosion surface. These differences conﬁrm the
altered microarchitectural state in OA bone compared to CTL10,36,37.
This suggests that primary hip OA is a disease characterised by
altered expression of critical molecular regulators in the bone
Fig. 2. a) TWIST1 mRNA expression from the IT region of the proximal femur of OA
patients (n¼ 23) and CTL cases (n¼ 21), data are expressed as non-parametric median
and inter-quartile range (P¼ 0.002). (b) Percent bone volume fraction (BV/TV) from the
IT region of the proximal femur of OA patients and CTL cases, data are expressed as
median and inter-quartile range (P¼ 0.009). (c) Signiﬁcant positive correlation with
95% conﬁdence interval (r¼þ0.567) between TWIST1 and BV/TV from the IT region of
the proximal femur in CTL (P¼ 0.043), no signiﬁcant correlation was observed in OA.
Table II
Correlations in gene expression amongst molecular regulators and between struc-
tural indices in OA patients and CTL cases*
OA CTL
Genetic correlations
PTEN vs S100A4 r¼þ0.519, P¼ 0.011 r¼þ0.202, P¼ 0.381
PTEN vs TIMP4 r¼þ0.374, P¼ 0.126 r¼þ0.559, P¼ 0.024
CTNNB1 vs MMP25 r¼þ0.599, P¼ 0.003 r¼þ0.500, P¼ 0.021
CTNNB1 vs IL10 r¼0.534, P¼ 0.011 r¼þ0.246, P¼ 0.325
TWIST1 vs CTNNB1 r¼0.447, P¼ 0.032 r¼þ0.024, P¼ 0.923
TWIST1 vs S100A4 r¼þ0.712, P< 0.001 r¼0.305, P¼ 0.204
TWIST1 vs PTEN r¼þ0.581, P¼ 0.004 r¼þ0.239, P¼ 0.325
TWIST1 vs TIMP4 r¼þ0.799, P< 0.001 r¼þ0.050, P¼ 0.861
SMAD3 vs CTNNB1 r¼0.463, P¼ 0.026 r¼0.205, P¼ 0.386
SMAD3 vs CD14 r¼þ0.564, P¼ 0.005 r¼þ0.602, P¼ 0.005
SMAD3 vs MMP25 r¼0.468, P¼ 0.028 r¼0.346, P¼ 0.136
S100A4 vs IL10 r¼þ0.720, P< 0.001 r¼0.033, P¼ 0.897
S100A4 vs CTNNB1 r¼0.472, P¼ 0.023 r¼0.188, P¼ 0.414
MMP25 vs IL10 r¼0.340, P¼ 0.131 r¼þ0.540, P¼ 0.021
Histomorphometric correlations
BV/TV vs Tb.N r¼þ0.535, P¼ 0.015 r¼þ0.610, P¼ 0.021
BV/TV vs Tb.Sp r¼0.501, P¼ 0.024 r¼0.710, P¼ 0.006
BV/TV vs Tb.Th r¼þ0.783, P< 0.001 r¼þ0.004, P¼ 0.669
Tb.N vs Tb.Sp r¼0.352, P¼ 0.128 r¼0.891, P< 0.001
Tb.N vs O.Th r¼0.406, P¼ 0.094 r¼0.665, P¼ 0.009
Tb.Sp vs O.Th r¼þ0.189, P¼ 0.452 r¼þ0.711, P¼ 0.007
Tb.Th vs 0.Th r¼0.196, P¼ 0.452 r¼þ0.673, P¼ 0.011
* Sampled from the IT region of the proximal femur (trabecular bone). Correla-
tions are expressed as r values, statistical signiﬁcance was set at P< 0.05. Gene
expression data were normalized to GAPDH. Only correlations signiﬁcant in one or
both cohorts are presented, all other correlations were not signiﬁcant.
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remodelling and thus differences in structural parameters, consis-
tent with previous reports8,11,18,39.
Correlations in gene expression
PTEN and S100A4 mRNA expression correlated positively in OA.
Since both molecules are associated with inhibition of osteoblast
differentiation and mineralisation, this suggests that both may
contribute to the dysfunctional osteoblast differentiation and
mineralisation exhibited in OA26,40. Conversely, the positive
correlation between PTEN and TIMP4, an inhibitor of MMPs, wasobserved in CTL bone but not in the OA cohort. This suggests that
normal regulatory mechanisms controlling bone turnover are not
conserved in OA bone26,36. Positive correlations in gene expression
were observed between the key osteoblast transcription factor,
CTNNB1, and thematrix modifying enzyme, MMP25, in both the OA
and CTL cohorts (Table III)39e41. Furthermore, expression of both
genes was not different between the two cohorts. This relationship
may represent a level of balance in bone remodelling that is
conserved in OA, despite the dysfunction between other lineage
allocation markers and matrix resorption. However, CTNNB1
expression in OA bone was associated unusually with other
important regulatory genes. For example, CTNNB1 and IL10 corre-
lated negatively only in the OA cohort, this association between an
osteoblastogenic regulator and an osteoclastogenic inhibitor also
contributes to the altered state of remodelling observed in OA34,41.
TWIST1 correlated negatively with CTNNB1 and positively with
S100A4, PTEN and TIMP4 exclusively in the OA cohort. Negative
correlation between these two critical transcription factors,
suggests the emergence of a dysfunctional relationship leading to
abnormal osteoblast differentiation, based on the known roles of
these molecules in the bone microenvironment8. S100A4 is
a negative regulator of mineralisation that maybe downstream of
TWIST140. In the present study, primary hip OA patients expressed
TWIST1 in positive correlationwith S100A4, whereas no signiﬁcant
correlationwas observed in CTLs. This suggests that although lower
levels of TWIST1 are observed in the OA trabecular bone, its regu-
latory action is associated with the inhibition of normal minerali-
sation in OA bone. Also, TWIST1 mRNA expression correlated
positively with that of PTEN in OA, consistent with abnormal
osteoblast differentiation and reduced calcium apposition in OA26.
TIMP4 mRNA expression also increased with that of TWIST1 in OA.
This relationship is also consistent with the increased BV/TV, Tb.N
and decreased Tb.Sp observed in the OA trabecular bone. Negative
correlations between SMAD3 and CTNNB1 expression, as well as
MMP25 in OA suggest the emergence of further dependencies not
seen in the CTL cohort. Based on the roles of SMAD3 and CTNNB1 in
Table III
Correlations in gene expression amongst molecular regulators and structural and




CTNNB1 vs OS/BS r¼0.069, P¼ 0.772 r¼þ0.655, P¼ 0.011
CTNNB1 vs OS/BV r¼0.239, P¼ 0.310 r¼þ0.652, P¼ 0.012
CTNNB1 vs OV/BV r¼þ0.060, P¼ 0.810 r¼þ0.607, P¼ 0.021
TWIST1 vs BV/TV r¼þ0.011, P¼ 0.964 r¼þ0.567, P¼ 0.043
ADFP vs Tb.Sp r¼0.511, P¼ 0.021 r¼þ0.181, P¼ 0.554
ADFP vs OS/ES r¼0.397, P¼ 0.083 r¼þ0.542, P¼ 0.045
IL10 vs BV/TV r¼0.436, P¼ 0.062 r¼þ0.679, P¼ 0.015
MMP25 vs ES/BS r¼þ0.491, P¼ 0.033 r¼0.049, P¼ 0.869
MMP25 vs ES/BV r¼þ0.464, P¼ 0.046 r¼þ0.250, P¼ 0.410
MMP25 vs ES/TV r¼þ0.583, P¼ 0.011 r¼0.250, P¼ 0.389
TIMP4 vs O.Th r¼0.233, P¼ 0.423 r¼þ0.660, P¼ 0.027
* Sampled from the IT region of the proximal femur (trabecular bone). Correla-
tions are expressed as r values, statistical signiﬁcance was set at P< 0.05. Gene
expression data were normalized to GAPDH. Only correlations signiﬁcant in one or
both cohorts are presented, all other correlations were not signiﬁcant.
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also indicates irregular activity within theWNTand TGFb pathways
in the OA trabecular bone41,42. The negative correlation between
MMP25 and SMAD3 expression may also contribute to the higher
bone volume fraction observed in OA, as the inhibitory action of
SMAD3 may be further augmented by a decrease in the turnover of
the bone matrix43,44. The positive correlations observed between
SMAD3 and CD14 in both the OA and CTL cohorts may represent
conserved signalling pathways in cells of the granulocyte and
monocytic lineages in both cohorts. The elevated expression of both
these genes in OA is consistent with increased inﬂammatory cell
activity in OA bone31. The negative correlation between S100A4 and
CTNNB1 is consistent with abnormal differentiation of osteoblasts
and bone formation in OA10,40. The positive correlation between
S100A4 and IL10 in OA suggests that, as normal differentiation and
mineralisation is inhibited, osteoclastogenesis may also be inhibi-
ted within the trabecular bone of the pathology, consistent with
previous observations in OA34,45. MMP25 and IL10 correlated
positively exclusively in the CTL cohort, suggesting that as degra-
dation of the extracellular matrix increases, osteoclastogenesis is
inhibited in the CTL cohort34,43,46. This relationship is not present in
the OA cohort, consistent with the disruption of the bone remod-
elling process in this pathology. Together, these ﬁndings indicate
that the altered state of remodelling found in OA bone may be
driven by a complex aberrant program of gene expression among
molecular regulators of osteoblast differentiation, mineralisation
and bone turnover. This may ultimately lead to the altered bone
structure in OA, indicated by the observed changes in the bone
histomorphometric indices.Correlations among histomorphometric indices
Among the histomorphometric indices assessed in this study,
a positive correlation between BV/TV and Tb.N, and a negative
correlation between BV/TV and Tb.Sp were observed, as found in
previous studies. Conservation of these correlations in both cohorts
conﬁrms that although there is higher bone volume fraction in OA,
increases in BV/TV are concomitant with increases in Tb.N and
decreases in Tb.Sp, similar to CTLs15,47,48. In the CTL cohort, the
negative correlation between Tb.N and Tb.Sp is consistent with
previous ﬁndings20. However, these did not correlate in OA. Tb.N
and O.Th also correlated negatively, and Tb.Sp and O.Th correlated
positively, just in CTL. Thus, alongside the conservation of the
correlations between BV/TV and Tb.Sp and between BV/TV andTb.N, the absence of other correlations may indicate partially
altered structural relationships in the OA bone.
Correlations between gene expression and histomorphometry
In this study the signiﬁcant correlations found in CTL
bone, between CTNNB1 expression and the three formation indices
(OS/BS, OS/BV and OV/BV) were not observed in OA bone. This
suggests that WNT/b-catenin control of osteoblast differentiation
and bone formation is fundamentally altered in OA and is consis-
tent with the altered bone formation and decreased mineralisation
state observed in this pathology10,41. In CTL bone the correlation
between TWIST1 and BV/TV is consistent with the role of this
transcription factor in osteoblast differentiation, contributing to the
process of bone formation28. This relationship is not maintained in
OA, suggesting the dysfunctional differentiation of the osteoblast in
OA may also in part be driven by altered TWIST1 activity. ADFP
correlated positively with OS/ES in the CTL cohort indicating an
increase in adipocytic cells alongside the increased osteoid surface.
This relationship is not maintained in the OA cohort, consistent
with aberrant lineage allocation in OA8. IL10 and BV/TV correlated
positively in CTL but not in OA. IL10 expression inhibits osteoclas-
togenesis; as such, positive correlationwith bone volume in the CTL
cohort is consistent with the known roles of this gene34. The loss of
this relationship in OAmay add to an altered state of remodelling in
the pathology. The signiﬁcantly lower resorption indices observed
in OA (ES/BS and ES/BV), as well as ES/TV, correlate positively with
MMP25 expression, exclusively in the pathology. Secretion of this
molecule can indirectly activate serine proteinases capable of
damaging the extracellular matrix43. These associations indicate
that although lower resorption indices are observed in OA, the
resorption that does occur, maybe in part mediated by MMP25.
TIMP4 is a known inhibitor of MMPs, and correlates positively with
O.Th in CTL bone. Increased inhibition of degradative proteinases is
consistent with increases in O.Th37. The loss of this correlation in
OA is consistent with increased MMP activity as found in other
studies, and the abnormal process of formation observed among
the previous correlations in this study30.
Notably the expression of some key factors did not show overt
differences between OA patients and CTL, such as CTNNB1,
S100A4 and MMP25, whereas their link with histomorphometric
parameters showed different correlations between OA and CTL.
These differences indicate that other factors might be important
or masked herein, in order to understand the links established
here. Further studies are needed to investigate these links. Also,
further investigation of sex-related differences within OA and CTL
maybe undertaken, with a speciﬁcally designed study for this
purpose to further examine the differences and correlations
established here.
In the present study the sample size consisted of 23 OA and 21
CTL cases, these two cohorts were similar in number to other
studies (24 OA and 21 CTL, or 19 OA and 25 CTL) and were also age
and sex-matched8,12. The examination was undertaken in the IT
region, in order to evaluate systemic changes in hip OA in proximity
of the bony compartment of the disease, away from the diseased
surface8,12. A characteristic of this study is that it combined two
analytical techniques, both real-time PCR and histology, on the
same bone biopsy, enabling complementary assessment of both
gene expression and histomorphometry on each case.
In summary, this study investigated changes in gene expression
and histomorphometric indices, as well as the correlations between
these measures in OA and CTL from human IT trabecular bone. The
ﬁndings suggest that OA is characterised by an altered state of
osteoblast differentiation and function, driven by differential
expression of critical molecular regulators. This differential
D.D. Kumarasinghe et al. / Osteoarthritis and Cartilage 18 (2010) 1337e1344 1343expression was found to associate with an altered state of remod-
elling, resulting in increased bone volume fraction and altered
trabecular microarchitecture in the pathology.
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